全球内视镜手术液体管理系统市场－市场规模（依细分市场划分）、占有率、监管、报销、营运数量及预测（至2036年）

本报告深入探讨并分析了全球内视镜手术液体管理系统市场，提供了区域市场规模、关键趋势、创新产品和技术以及竞争格局等资讯。 市场模型的主要组成如下：

已上市的内视镜手术液体管理系统及不断演变的竞争格局

• 关键产业趋势探讨
• 内视镜手术液体管理系统市场各细分领域的年度收入和市场预测（2015-2036 年）
• 各细分领域的总营运单位数、销售量、平均售价及市场价值的详细资料

全球、区域与国家层面各市场的探讨

• 依地区和国家划分的定性市场资讯及市场分析
• 内视镜手术液体管理系统市场的 SWOT 分析
• 内视镜手术液体管理系统市场的竞争动态与趋势探讨

全面的视角，包括对医疗保健系统的概述，有助于更好地理解市场。 此外，市场参与细分还提供有关报销政策和监管环境的信息，从而可以更深入地了解市场动态。

• 各国医疗保健系统概览
• 报销政策
• 医疗科技监管环境

对象企业

• Stryker Corp
• B. Braun Melsungen AG
• Hologic Inc
• Medtronic Plc
• Olympus Corp
• Cardinal Health Inc
• KARL STORZ SE & Co KG
• 其他

Endoscopy Fluid Management Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.

Endoscopy Fluid Management Systems are used for the irrigation and /or aspiration of fluids into or from a surgical work site during an endoscopic procedure. Endoscopy Fluid Management Systems are used during minimally invasive surgery for the purpose of performing any one of a variety of irrigation/aspiration functions such as tissue lavage, uterine distension, and others.

Endoscopy Fluid Management Systems are used during endoscopic examinations such as laparoscopy and hysteroscopy to enhance visibility. The goal of these devices is to improve visibility by managing fluid near and within the surgical site which is accomplished by irrigation and suction. In addition, these devices manage pressure within the surgical site creating favorable operating environments. Irrigation pumps are the most commonly used form of endoscopy fluid management systems; these are used along with endoscopes during minimally invasive (MIS) Interventions.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Endoscopy Fluid Management Systems and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Endoscopy Fluid Management Systems market revenue by segment and market outlooks from 2015-2036.
• Granular data on total installed base, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Endoscopy Fluid Management Systems market.
• Competitive dynamics insights and trends provided for Endoscopy Fluid Management Systems market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Stryker Corp, B. Braun Melsungen AG, Hologic Inc, Medtronic Plc, Olympus Corp, Cardinal Health Inc, KARL STORZ SE & Co KG, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Endoscopy Fluid Management Systems marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Endoscopy Fluid Management Systems market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Endoscopy Fluid Management Systems market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Endoscopy Fluid Management Systems market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.